Branch atheromatous disease and treatment

Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal tr...

Full description

Bibliographic Details
Main Authors: Honglian Duan, Ho Jun Yun, Xiaokun Geng, Yuchuan Ding
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Brain Circulation
Subjects:
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2022;volume=8;issue=4;spage=169;epage=171;aulast=Duan
_version_ 1797955101865803776
author Honglian Duan
Ho Jun Yun
Xiaokun Geng
Yuchuan Ding
author_facet Honglian Duan
Ho Jun Yun
Xiaokun Geng
Yuchuan Ding
author_sort Honglian Duan
collection DOAJ
description Branch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis.
first_indexed 2024-04-10T23:29:03Z
format Article
id doaj.art-efa0605e7bb7421fa4efa9024d4b0523
institution Directory Open Access Journal
issn 2455-4626
language English
last_indexed 2024-04-10T23:29:03Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Brain Circulation
spelling doaj.art-efa0605e7bb7421fa4efa9024d4b05232023-01-12T11:17:58ZengWolters Kluwer Medknow PublicationsBrain Circulation2455-46262022-01-018416917110.4103/bc.bc_56_22Branch atheromatous disease and treatmentHonglian DuanHo Jun YunXiaokun GengYuchuan DingBranch atheromatous disease (BAD) is a subtype of ischemic stroke caused by perforating arteries occlusion due to proximal atherosclerosis of the arteries. Early neurological deterioration and recurrent stereotyped transient ischemic attacks are typical clinical manifestations of BAD. The optimal treatment for BAD has not been determined. This article explores a possible mechanism of BAD and effective treatment measures to prevent early progression and attack of transient ischemic events. This article explains the current status of intravenous thrombolysis, tirofiban, and argatroban for BAD and subsequent prognosis.http://www.braincirculation.org/article.asp?issn=2394-8108;year=2022;volume=8;issue=4;spage=169;epage=171;aulast=Duanargatrobanbranch atheromatous diseaseearly neurological deteriorationintravenous thrombolytic therapytirofiban
spellingShingle Honglian Duan
Ho Jun Yun
Xiaokun Geng
Yuchuan Ding
Branch atheromatous disease and treatment
Brain Circulation
argatroban
branch atheromatous disease
early neurological deterioration
intravenous thrombolytic therapy
tirofiban
title Branch atheromatous disease and treatment
title_full Branch atheromatous disease and treatment
title_fullStr Branch atheromatous disease and treatment
title_full_unstemmed Branch atheromatous disease and treatment
title_short Branch atheromatous disease and treatment
title_sort branch atheromatous disease and treatment
topic argatroban
branch atheromatous disease
early neurological deterioration
intravenous thrombolytic therapy
tirofiban
url http://www.braincirculation.org/article.asp?issn=2394-8108;year=2022;volume=8;issue=4;spage=169;epage=171;aulast=Duan
work_keys_str_mv AT honglianduan branchatheromatousdiseaseandtreatment
AT hojunyun branchatheromatousdiseaseandtreatment
AT xiaokungeng branchatheromatousdiseaseandtreatment
AT yuchuanding branchatheromatousdiseaseandtreatment